Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (11-20 of 627) with videos related to

Pageof 63
Sort By:
Current Cardiology Reports|December 14, 2011
Promises of PAR-1 inhibition in acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Kenneth W Mahaffey
Coronary Artery Disease|July 12, 2016
Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibitionLeo Ungar, Fatima Rodriguez, Kenneth W Mahaffey
Current Cardiology Reports|June 9, 2004
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromesAbhinav Goyal, John L Petersen, Kenneth W Mahaffey
Genetics|May 22, 2008
The Drosophila gap gene giant has an anterior segment identity function mediated through disconnected and teashirtLisa R Sanders, Mukund Patel, James W Mahaffey
Current Opinion in Cardiology|June 4, 2010
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillationJonathan P Piccini, Renato D Lopes, Kenneth W Mahaffey
Cardiology and Therapy|July 15, 2020
A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i)Sun H Kim, Tara I Chang, Kenneth W Mahaffey
Genetics|January 5, 2001
The Drosophila genes disconnected and disco-related are redundant with respect to larval head development and accumulation of mRNAs from deformed target genesJ W Mahaffey, C M Griswold, Q M Cao
The Annals of Pharmacotherapy|May 1, 1992
Danazol increases the anticoagulant effect of warfarinM L Meeks, K W Mahaffey, M D Katz
Development (Cambridge, England)|January 1, 1995
Control of Drosophila head segment identity by the bZIP homeotic gene cncJ Mohler, J W Mahaffey, E Deutsch, et al.
Drugs|January 27, 2005
Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selectionBrett D Atwater, Matthew T Roe, Kenneth W Mahaffey
Pageof 63

Showing results (11-20 of 627) with videos related to

Sort By:
Pageof 63
Current Cardiology Reports|December 14, 2011
Promises of PAR-1 inhibition in acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Kenneth W Mahaffey
Coronary Artery Disease|July 12, 2016
Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibitionLeo Ungar, Fatima Rodriguez, Kenneth W Mahaffey
Current Cardiology Reports|June 9, 2004
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromesAbhinav Goyal, John L Petersen, Kenneth W Mahaffey
Genetics|May 22, 2008
The Drosophila gap gene giant has an anterior segment identity function mediated through disconnected and teashirtLisa R Sanders, Mukund Patel, James W Mahaffey
Current Opinion in Cardiology|June 4, 2010
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillationJonathan P Piccini, Renato D Lopes, Kenneth W Mahaffey
Cardiology and Therapy|July 15, 2020
A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i)Sun H Kim, Tara I Chang, Kenneth W Mahaffey
Genetics|January 5, 2001
The Drosophila genes disconnected and disco-related are redundant with respect to larval head development and accumulation of mRNAs from deformed target genesJ W Mahaffey, C M Griswold, Q M Cao
The Annals of Pharmacotherapy|May 1, 1992
Danazol increases the anticoagulant effect of warfarinM L Meeks, K W Mahaffey, M D Katz
Development (Cambridge, England)|January 1, 1995
Control of Drosophila head segment identity by the bZIP homeotic gene cncJ Mohler, J W Mahaffey, E Deutsch, et al.
Drugs|January 27, 2005
Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selectionBrett D Atwater, Matthew T Roe, Kenneth W Mahaffey
Pageof 63